Compound Detail
CHEMBL404556
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
NC(=O)c1ncc2cc(-c3ccccc3)c(-c3ccc(CN4CCC(c5nnc(-c6ccccn6)[nH]5)CC4)cc3)nc2n1
Basic Information
| ChEMBL ID | CHEMBL404556 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | MKCRPVFQAIQPQA-UHFFFAOYSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
567.7
MW (Da)
5.02
ALogP
8
HBA
2
HBD
139.5
PSA (Ų)
0.27
QED
2
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 8.21
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase CHEMBL4282 | IC50 | 8.21 | 7.615 | 6.2 | 2 |
| RAC-beta serine/threonine-protein kinase CHEMBL2431 | IC50 | 7.46 | 6.445 | 35.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| RAC-alpha serine/threonine-protein kinase | IC50 | = | 6.2 | nM | 8.21 | Inhibition of Akt1 | 18249537 |
| RAC-beta serine/threonine-protein kinase | IC50 | = | 35.0 | nM | 7.46 | Inhibition of Akt2 | 18249537 |
| RAC-alpha serine/threonine-protein kinase | IC50 | = | 96.4 | nM | 7.02 | Inhibition of human Akt1 in human C33A cells by immunoprecipitation kinase assay | 18249537 |
| RAC-beta serine/threonine-protein kinase | IC50 | = | 3706.0 | nM | 5.43 | Inhibition of Akt2 in human C33A cells by immunoprecipitation kinase assay | 18249537 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 18249537 | 10.1016/j.bmcl.2008.01.054 | RAC-alpha serine/threonine-protein kinase | 2 |
| 18249537 | 10.1016/j.bmcl.2008.01.054 | RAC-beta serine/threonine-protein kinase | 2 |
Data from ChEMBL 36 via Core Engine